Oncology News

From the World Conference on Lung Cancer 2022:
Around a fifth of patients with thoracic cancer die within 30 days of COVID-19 infection but the risk is not predicted by recent receipt of systematic treatment for their malignancy

From the World Conference on Lung Cancer 2022:
Some participants of the KEYNOTE-604 trial with extensive-stage small-cell lung cancer have derived long-term survival benefits from the use of pembrolizumab plus etoposide

From the World Conference on Lung Cancer 2022:
NADIM II shows combining neoadjuvant chemotherapy with nivolumab before and after surgery improves progression-free and overall survival in resectable stage IIIA–B non-small-cell lung cancer